Tag Archives: Neuroprotection

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Posted on September 19, 2019 by

Recent studies indicate that higher strength disease modifying therapies (DMTs) may slow disability progression in secondary progressive multiple sclerosis (MS), as well as reduce the number of relapses. There have also been trials in primary progressive MS but these, most … Continue reading →

Posted in Inflammatory/ Auto-Immune Diseases | Tagged , , , , | 1 Comment

Journal Club Review: A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease

Posted on January 12, 2013 by

Summary for General Readers Given it was first introduced to treat Parkinson’s disease in the 1960’s (see the accompanying background information on Parkinson’s disease for general readers), it is surprising that it was not until four decades later that a major … Continue reading →

Posted in Parkinson's Disease | Tagged , , , | Leave a comment